1276732-89-8
1276732-89-8
Chemical Structure
Carbidopa-d3
- CAS No.: 1276732-89-8
- Formula:C10H11D3N2O4
- Molecular Weight:229.25
InChIKey: TZFNLOMSOLWIDK-RPACEKEXSA-N
SMILES: OC(C([2H])=C1C[C@@](NN)(C)C(O)=O)=C(C([2H])=C1[2H])O
Biological Activity: Carbidopa-d3 is the deuterium labeled Carbidopa[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Carbidopa-d3 | 99.76% | Carbidopa-d3 is the deuterium labeled Carbidopa. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbidopa (Standard) | ≥98% | Carbidopa (Standard) is the analytical standard of Carbidopa. This product is intended for research and analytical applications. Carbidopa ((S)-(-)-Carbidopa), a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa inhibits pancreatic cancer cell and tumor growth. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbidopa-d3-1 | Carbidopa-d3-1 is the deuterium labeled Carbidopa (HY-B0311). Carbidopa, a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa inhibits pancreatic cancer cell and tumor growth. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbidopa | 99.84% | Carbidopa ((S)-(-)-Carbidopa), a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa inhibits pancreatic cancer cell and tumor growth. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
